BRAFV600E-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma

Authors:

Abstract
Oncotarget | https://doi.org/10.18632/oncotarget.27326 M. Herman Chui, Susanne K. Kjaer, Kirsten Frederiksen, Charlotte G. Hannibal, Tian-Li Wang, Russell Vang, Ie-Ming Shih

This publication has 14 references indexed in Scilit: